Literature DB >> 31482533

Equilibrium radionuclide angiography: Present and future.

Guillermo Romero-Farina1,2, Santiago Aguadé-Bruix3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31482533     DOI： 10.1007/s12350-019-01876-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  8 in total

Review 1.  Equilibrium radionuclide ventriculography: still a clinically useful method for the assessment of cardiac function?

Authors:  Christos Sachpekidis; Vasileios Sachpekidis; Efstratios Moralidis; Georgios Arsos
Journal:  Hell J Nucl Med       Date:  2018 Sep-Dec       Impact factor: 1.102

2.  Left ventricular ejection fraction determined with the simulation of a very low-dose CZT-SPECT protocol and an additional count-calibration on planar radionuclide angiographic data.

Authors:  Hubert Tissot; Véronique Roch; Olivier Morel; Nicolas Veran; Mathieu Perrin; Marine Claudin; Antoine Verger; Gilles Karcher; Pierre-Yves Marie; Laetitia Imbert
Journal:  J Nucl Cardiol       Date:  2019-02-27       Impact factor: 5.952

3.  Mediastinal T-lymphoblastic lymphoma mimicking invasive thymoma on 18F-FDG PET/CT in a young patient.

Authors:  Huipan Liu; Yue Chen
Journal:  J Nucl Cardiol       Date:  2019-10-10       Impact factor: 5.952

4.  Left ventricle function assessment using gated first-pass 18F-FDG PET: Validation against equilibrium radionuclide angiography.

Authors:  Fayçal Ben Bouallègue; Laurent Maïmoun; Florentin Kucharczak; Pierre Le Fur; Fabien Vauchot; Boramy Hay; Eric Rondet; Denis Mariano-Goulart
Journal:  J Nucl Cardiol       Date:  2019-05-01       Impact factor: 5.952

5.  Comparison of two dipyridamole infusion protocols for myocardial perfusion imaging in subjects with low likelihood of significant obstructive coronary artery disease.

Authors:  Francois Harel; Vincent Finnerty; Sébastien Authier; Matthieu Pelletier-Galarneau
Journal:  J Nucl Cardiol       Date:  2018-10-26       Impact factor: 5.952

6.  Value of 12-lead electrocardiogram to predict myocardial scar on FDG PET in heart failure patients.

Authors:  Susanne Markendorf; Dominik C Benz; Michael Messerli; Marvin Grossmann; Andreas A Giannopoulos; Dimitri Patriki; Tobias A Fuchs; Christoph Gräni; Aju P Pazhenkottil; Ronny R Buechel; Philipp A Kaufmann; Oliver Gaemperli
Journal:  J Nucl Cardiol       Date:  2019-08-09       Impact factor: 5.952

7.  Equilibrium radionuclide angiography: Intra- and inter-observer repeatability and reproducibility in the assessment of cardiac systolic and diastolic function.

Authors:  Christos Sachpekidis; Vasileios Sachpekidis; Annette Kopp-Schneider; George Arsos; Efstratios Moralidis
Journal:  J Nucl Cardiol       Date:  2019-08-05       Impact factor: 5.952

Review 8.  Nuclear cardiology in the context of multimodality imaging to detect cardiac toxicity from cancer therapeutics: Established and emerging methods.

Authors:  Aaron Soufer; Chi Liu; Mariana L Henry; Lauren A Baldassarre
Journal:  J Nucl Cardiol       Date:  2019-03-13       Impact factor: 3.872
  8 in total
  3 in total

1.  Low-dose dobutamine stress gated blood pool SPECT assessment of left ventricular contractile reserve in ischemic cardiomyopathy: a feasibility study.

Authors:  Vladimir V Shipulin; Sergey L Andreev; Andrew S Pryakhin; Andrew V Mochula; Alina N Maltseva; Svetlana I Sazonova; Vladimir M Shipulin; Samia Massalha; Konstantin V Zavadovsky
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-02-12       Impact factor: 10.057

2.  Cardiac CZT-SPECT: More than left ventricular imaging.

Authors:  Bo Zerahn; Christian Haarmark
Journal:  J Nucl Cardiol       Date:  2021-06-24       Impact factor: 3.872

Review 3.  Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology.

Authors:  David Kersting; Stephan Settelmeier; Ilektra-Antonia Mavroeidi; Ken Herrmann; Robert Seifert; Christoph Rischpler
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.